<code id='66DEE868FB'></code><style id='66DEE868FB'></style>

<acronym id='66DEE868FB'></acronym>

<center id='66DEE868FB'><center id='66DEE868FB'><tfoot id='66DEE868FB'></tfoot></center><abbr id='66DEE868FB'><dir id='66DEE868FB'><tfoot id='66DEE868FB'></tfoot><noframes id='66DEE868FB'>

<optgroup id='66DEE868FB'><strike id='66DEE868FB'><sup id='66DEE868FB'></sup></strike><code id='66DEE868FB'></code></optgroup>

<b id='66DEE868FB'><label id='66DEE868FB'><select id='66DEE868FB'><dt id='66DEE868FB'><span id='66DEE868FB'></span></dt></select></label></b><u id='66DEE868FB'></u>

~~<i id='66DEE868FB'><strike id='66DEE868FB'><tt id='66DEE868FB'><pre id='66DEE868FB'></pre></tt></strike></i>~~

Home» comprehensive» leisure time

leisure time

leisure time

author：fashion 2025-10-02 12:53:52 Page View：11355

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

advertisement

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Artificial intelligence advances fuel industry trying to preserve loved ones after death
Next article： Peter Hotez and the public health issue of online harassment

explore

Activists slam private health insurers over coverage restrictions

Activists slam private health insurers over coverage restrictions

ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

Oak Street deal isn't the answer to health care's woes

Oak Street deal isn't the answer to health care's woes

JustinSullivan/GettyImagesCVSHealth’sacquisitionofOakStreetHealth,aMedicare-focusedprimarycareprovid

United colonoscopy coverage change 'may cost lives,' doctors say

United colonoscopy coverage change 'may cost lives,' doctors say

AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

CDC backtracks, saying fully vaccinated people can go maskless indoors

CHRISDELMAS/AFPviaGettyImagesWASHINGTON—TheCentersforDiseaseControlandPreventiononThursdaysaidpeople

read more